Adjuvant discovery program

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201400053C
Awardee
Awarding agency
Obligated
$11,281,569

Award facts

Opportunity
Contract value 100% obligated
$11,281,569.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 16 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Australia

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00014 -$4,922
Change Order P00013 $500,000
Change Order P00012 $413,000
Other Administrative Action P00011 $0
Other Administrative Action 10 $0
Exercise an Option 9 $1,904,860
Other Administrative Action 8 $0
Other Administrative Action 7 $0
Other Administrative Action 6 $0
Change Order 5 $320,000
Change Order 3 $140,000
Change Order 4 $140,000
Change Order 2 $120,000
Other Administrative Action 1 $0
Original award $7,748,631
Show all 15

Quick answers

Who was awarded contract HHSN272201400053C?

HHSN272201400053C was awarded to Vaxine PTY LTD by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 23, 2014.

How much is contract HHSN272201400053C worth?

The government has obligated $11,281,569 on HHSN272201400053C.

Was contract HHSN272201400053C competed?

The extent of competition for HHSN272201400053C was full and open competition. The government received 16 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login